Now Accepting Patients NBC News Producer Personal Journey – It’s all About Early Detection & Prevention – Hawaii First Alzheimer’s Prevention Trial – PrevenTRON now Accepting Patients PrevenTRON, Phase 3 Prevention Trial of Trontinemab in Cognitively Unimpaired Individuals at High…
Honolulu, September 2026 The neurologists, research staff and coordinators of the Hawaii Memory Disorders Center & Alzheimer’s Research Unit. Hawaii’s first Alzheimer’s prevention trial is now accepting patients. Hawaii Pacific Neuroscience has been selected as the Hawaii site for PrevenTRON,…
Honolulu, July 2026 A University of Hawai‘i professor and Hawaii neurologist has been asked to serve on the Advisory Council of the International Society to Advance Alzheimer’s Research and Treatment (ISTAART), the professional society of the Alzheimer’s Association. The appointment…
Hawaii Memory Center & Alzheimer’s Research Unit to Present EEG Biomarker Research at the 2026 London AAIC Our team is proud to collaborate with Advanced Brain Monitoring to present new findings at the 2026 Alzheimer’s Association International Conference (AAIC) in…
Alzheimer’s Research · Hawaii Memory & Alzheimer’s Research Unit · Published in Nature 2026 University of Hawaii Professor & Researcher Publishes Buntanetap Study in Nature — A Novel Oral Therapy Targeting APP and Tau in Alzheimer’s Disease npj Dementia, Nature…
Matthew Kobylinski 1 2, Nina Krupa 1 2, Hollis Tam 1, Linda Nguyen 1, Julia R Jahansooz 1 2, Kylie Herndon 1 3, Kaelyn Pacpaco 1 4, Masako Matsunaga 2, Samuel Toh Kim 1, Qi Zhi 1, Michael Sonson 1,…
Blood Biomarkers, Latest Treatments, and Brain Health Insights Alzheimer’s disease is one of the most talked-about—and misunderstood—neurological conditions today. With constant news headlines, social media discussions, and emerging research, patients and families are often left confused about what is true,…
DEBUNKING MYTHS, MISINFORMATION, CONTROVERSIES ON ALZHEIMER’S BLOOD BIOMARKERS, LATEST TREATMENTS & BRAIN HEALTH TIPS from US POINTER STUDY. This week on KHON2’s Working For Hawaii: Unscripted, we sat down with Dr. Kore Liow, a neurologist and Alzheimer’s expert, for an…
Hawaii Memory & Alzheimer’s Research has joined leading academic institutions—including UCSF, UC San Diego, and the Cleveland Clinic—in a multicenter clinical trial investigating VHB937, a novel TREM2-stabilizing monoclonal antibody engineered to cross the blood–brain barrier and reduce neuroinflammation in Alzheimer’s…
ERP Biomarkers of Cognitive Dysfunction in Alzheimer’s Disease: Real-World Evidence Supporting Translational Clinical Trial Endpoints Advances in neuroscience and digital biomarkers are transforming how clinicians and researchers detect, monitor, and study Alzheimer’s disease (AD). At the 2025 Clinical Trials on…